Market Cap 24.95M
Revenue (ttm) 640,000.00
Net Income (ttm) -69.90M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -10,921.88%
Debt to Equity Ratio -0.95
Volume 261,128
Avg Vol 987,844
Day's Range N/A - N/A
Shares Out 30.88M
Stochastic %K 57%
Beta 0.27
Analysts Strong Sell
Price Target $14.60

Company Profile

BioXcel Therapeutics, Inc., together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology in the United States. The company IGALMI, a sublingual film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. It also develops its neuroscience candidate, BXCL501, which is an investigational, proprietary, orally...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 475 238 6837
Address:
555 Long Wharf Drive, 12th Floor, New Haven, United States
StickyRice5507
StickyRice5507 Aug. 4 at 1:15 PM
0 · Reply
WenABVEAudit
WenABVEAudit Aug. 3 at 4:12 PM
$BTAI people smarter than us, seem to think this was good news today
0 · Reply
wndyctyboy1975
wndyctyboy1975 Aug. 3 at 3:46 PM
$BTAI bunch of holes in this boat but some how it still floats tiny bit of hope left
0 · Reply
Tonyboner
Tonyboner Aug. 3 at 2:05 PM
$BTAI They got no money !
1 · Reply
Paxhawig
Paxhawig Aug. 3 at 11:25 AM
$BTAI bullshit
0 · Reply
SrTxan
SrTxan Aug. 3 at 11:22 AM
$BTAI $BTAI Eleventh Amendment confirmed. Oaktree has once again deferred the approximately $9.02M payment, this time until August 31, and lowered the minimum liquidity requirement from $7.5M to $6.25M. But the real deadline is August 10: BioXcel must sign definitive agreements acceptable to the lenders that provide either full repayment of the debt or an alternative capital solution. They’re playing with us.
3 · Reply
Investeermeermeneer
Investeermeermeneer Aug. 3 at 11:08 AM
$BTAI deadline pushed again. Payment by aug 31, aug 10 deadline
0 · Reply
TraderNice
TraderNice Aug. 2 at 10:49 PM
$BTAI Three months until the Approval decision…we will know more soon.
1 · Reply
SrTxan
SrTxan Jul. 31 at 8:32 PM
$BTAI “D-Day” closed with no announcement. Could be good, could be bad. I’m not going to speculate on possibilities because only the people involved know what happened. The one thing we know for certain is that no debt acceleration has been publicly disclosed. If they reached an agreement today, they have four business days to disclose it to the market, so potentially through Thursday, August 6. If not, it should be addressed in the Q2 10 Q, where the company would be expected to discuss material subsequent events, including the outcome of these negotiations, if applicable. It’s also worth remembering this wouldn’t be the first time BTAI has gone past a contractual deadline. Oaktree required the company to retain an investment bank back in November 2024, yet one wasn’t hired until July 29, 2025. Eight months and three amendments (Sixth, Seventh and Eighth) just to move that date. I’ll wait for the filings. They’ll tell us what really happened.
0 · Reply
PolyesterJacket
PolyesterJacket Jul. 31 at 8:14 PM
$BTAI I know it's hard to believe, but management was silent today. This is very uncharacteristic for them.
2 · Reply
Latest News on BTAI
BioXcel Therapeutics reports Q1 EPS (54c), consensus (49c)

2026-05-15T12:03:32.000Z - 2 months ago

BioXcel Therapeutics reports Q1 EPS (54c), consensus (49c)


BioXcel Therapeutics Quarterly report: Q1 2026

May 15, 2026, 7:00 AM EDT - 2 months ago

BioXcel Therapeutics Quarterly report: Q1 2026


BioXcel Therapeutics Earnings release: Q1 2026

May 15, 2026, 7:00 AM EDT - 2 months ago

BioXcel Therapeutics Earnings release: Q1 2026


BioXcel Therapeutics Transcript: Investor update

Apr 23, 2026, 2:00 PM EDT - 3 months ago

BioXcel Therapeutics Transcript: Investor update


BioXcel Therapeutics Slides: Investor update

Apr 23, 2026, 2:00 PM EDT - 3 months ago

BioXcel Therapeutics Slides: Investor update


BioXcel Therapeutics enrolls first patients in BXCL501 trial

2026-04-08T11:09:11.000Z - 4 months ago

BioXcel Therapeutics enrolls first patients in BXCL501 trial


BioXcel Therapeutics announces FDA acceptance of Igalmi sNDA

2026-04-01T11:09:26.000Z - 4 months ago

BioXcel Therapeutics announces FDA acceptance of Igalmi sNDA


BioXcel Therapeutics reports Q4 EPS (58c), consensus (63c)

2026-03-27T11:20:13.000Z - 4 months ago

BioXcel Therapeutics reports Q4 EPS (58c), consensus (63c)


BioXcel Therapeutics Annual report: Q4 2025

Mar 27, 2026, 7:00 AM EDT - 4 months ago

BioXcel Therapeutics Annual report: Q4 2025


BioXcel Therapeutics Earnings release: Q4 2025

Mar 27, 2026, 7:00 AM EDT - 4 months ago

BioXcel Therapeutics Earnings release: Q4 2025


BioXcel price target lowered to $6 from $10 at H.C. Wainwright

2026-03-05T13:59:23.000Z - 5 months ago

BioXcel price target lowered to $6 from $10 at H.C. Wainwright


BioXcel Therapeutics Transcript: Status update

Feb 27, 2026, 2:00 PM EST - 5 months ago

BioXcel Therapeutics Transcript: Status update


BioXcel Therapeutics submits sNDA to U.S. FDA for Igalmi

2026-01-20T12:06:39.000Z - 7 months ago

BioXcel Therapeutics submits sNDA to U.S. FDA for Igalmi


BioXcel Therapeutics appoints Pavao as acting CCO

2026-01-12T12:21:09.000Z - 7 months ago

BioXcel Therapeutics appoints Pavao as acting CCO


BioXcel Therapeutics Transcript: AGM 2025

Dec 12, 2025, 9:00 AM EST - 8 months ago

BioXcel Therapeutics Transcript: AGM 2025


BioXcel Therapeutics reports Q3 EPS ($2.18), consensus ($1.34)

2025-11-12T12:16:09.000Z - 9 months ago

BioXcel Therapeutics reports Q3 EPS ($2.18), consensus ($1.34)


BioXcel Therapeutics Quarterly report: Q3 2025

Nov 12, 2025, 7:00 AM EST - 9 months ago

BioXcel Therapeutics Quarterly report: Q3 2025


BioXcel Therapeutics Earnings release: Q3 2025

Nov 12, 2025, 7:00 AM EST - 9 months ago

BioXcel Therapeutics Earnings release: Q3 2025


BioXcel Therapeutics Proxy statement: Proxy Filing

Nov 12, 2025, 7:00 AM EST - 9 months ago

BioXcel Therapeutics Proxy statement: Proxy Filing


BioXcel Therapeutics Proxy statement: Proxy Filing

Oct 31, 2025, 8:00 AM EDT - 9 months ago

BioXcel Therapeutics Proxy statement: Proxy Filing


BioXcel Therapeutics regains compliance with Nasdaq

2025-09-18T11:11:17.000Z - 11 months ago

BioXcel Therapeutics regains compliance with Nasdaq


BioXcel Therapeutics Transcript: Study Result

Sep 10, 2025, 2:00 PM EDT - 11 months ago

BioXcel Therapeutics Transcript: Study Result


BioXcel Therapeutics Press release: Study Result

Sep 10, 2025, 2:00 PM EDT - 11 months ago

BioXcel Therapeutics Press release: Study Result


BioXcel Therapeutics Slides: Study Result

Sep 10, 2025, 2:00 PM EDT - 11 months ago

BioXcel Therapeutics Slides: Study Result


BioXcel Therapeutics Transcript: Study Update

Aug 27, 2025, 8:00 AM EDT - 1 year ago

BioXcel Therapeutics Transcript: Study Update


BioXcel Therapeutics Press release: Study Update

Aug 27, 2025, 8:00 AM EDT - 1 year ago

BioXcel Therapeutics Press release: Study Update


BioXcel Therapeutics Slides: Study Update

Aug 27, 2025, 8:00 AM EDT - 1 year ago

BioXcel Therapeutics Slides: Study Update


BioXcel's agitation drug meets main goal in at-home study

Aug 27, 2025, 7:29 AM EDT - 1 year ago

BioXcel's agitation drug meets main goal in at-home study


BioXcel Therapeutics Quarterly report: Q2 2025

Aug 12, 2025, 7:00 AM EDT - 1 year ago

BioXcel Therapeutics Quarterly report: Q2 2025


BioXcel Therapeutics Earnings release: Q2 2025

Aug 12, 2025, 7:00 AM EDT - 1 year ago

BioXcel Therapeutics Earnings release: Q2 2025


BioXcel Therapeutics Quarterly report: Q1 2025

May 12, 2025, 7:00 AM EDT - 1 year ago

BioXcel Therapeutics Quarterly report: Q1 2025


BioXcel Therapeutics Earnings release: Q1 2025

May 12, 2025, 7:00 AM EDT - 1 year ago

BioXcel Therapeutics Earnings release: Q1 2025


BioXcel Therapeutics Annual report: Q4 2024

Mar 27, 2025, 10:30 AM EDT - 1 year ago

BioXcel Therapeutics Annual report: Q4 2024


BioXcel Therapeutics Earnings release: Q4 2024

Mar 27, 2025, 10:30 AM EDT - 1 year ago

BioXcel Therapeutics Earnings release: Q4 2024


BioXcel Therapeutics Announces Reverse Stock Split

Feb 6, 2025, 7:00 AM EST - 1 year ago

BioXcel Therapeutics Announces Reverse Stock Split


BioXcel Therapeutics Proxy statement: Proxy Filing

Dec 30, 2024, 7:00 AM EST - 1 year ago

BioXcel Therapeutics Proxy statement: Proxy Filing


BioXcel Therapeutics Proxy statement: Proxy Filing

Dec 18, 2024, 7:00 AM EST - 1 year ago

BioXcel Therapeutics Proxy statement: Proxy Filing


BioXcel Therapeutics Announces Proposed Public Offering

Nov 21, 2024, 4:47 PM EST - 1 year ago

BioXcel Therapeutics Announces Proposed Public Offering


BioXcel Therapeutics Earnings Call Transcript: Q3 2024

Nov 14, 2024, 8:00 AM EST - 1 year ago

BioXcel Therapeutics Earnings Call Transcript: Q3 2024


BioXcel Therapeutics Quarterly report: Q3 2024

Nov 14, 2024, 8:00 AM EST - 1 year ago

BioXcel Therapeutics Quarterly report: Q3 2024


BioXcel Therapeutics Earnings release: Q3 2024

Nov 14, 2024, 8:00 AM EST - 1 year ago

BioXcel Therapeutics Earnings release: Q3 2024


BioXcel Therapeutics to Present at ThinkEquity Conference

Oct 29, 2024, 7:00 AM EDT - 1 year ago

BioXcel Therapeutics to Present at ThinkEquity Conference


StickyRice5507
StickyRice5507 Aug. 4 at 1:15 PM
0 · Reply
WenABVEAudit
WenABVEAudit Aug. 3 at 4:12 PM
$BTAI people smarter than us, seem to think this was good news today
0 · Reply
wndyctyboy1975
wndyctyboy1975 Aug. 3 at 3:46 PM
$BTAI bunch of holes in this boat but some how it still floats tiny bit of hope left
0 · Reply
Tonyboner
Tonyboner Aug. 3 at 2:05 PM
$BTAI They got no money !
1 · Reply
Paxhawig
Paxhawig Aug. 3 at 11:25 AM
$BTAI bullshit
0 · Reply
SrTxan
SrTxan Aug. 3 at 11:22 AM
$BTAI $BTAI Eleventh Amendment confirmed. Oaktree has once again deferred the approximately $9.02M payment, this time until August 31, and lowered the minimum liquidity requirement from $7.5M to $6.25M. But the real deadline is August 10: BioXcel must sign definitive agreements acceptable to the lenders that provide either full repayment of the debt or an alternative capital solution. They’re playing with us.
3 · Reply
Investeermeermeneer
Investeermeermeneer Aug. 3 at 11:08 AM
$BTAI deadline pushed again. Payment by aug 31, aug 10 deadline
0 · Reply
TraderNice
TraderNice Aug. 2 at 10:49 PM
$BTAI Three months until the Approval decision…we will know more soon.
1 · Reply
SrTxan
SrTxan Jul. 31 at 8:32 PM
$BTAI “D-Day” closed with no announcement. Could be good, could be bad. I’m not going to speculate on possibilities because only the people involved know what happened. The one thing we know for certain is that no debt acceleration has been publicly disclosed. If they reached an agreement today, they have four business days to disclose it to the market, so potentially through Thursday, August 6. If not, it should be addressed in the Q2 10 Q, where the company would be expected to discuss material subsequent events, including the outcome of these negotiations, if applicable. It’s also worth remembering this wouldn’t be the first time BTAI has gone past a contractual deadline. Oaktree required the company to retain an investment bank back in November 2024, yet one wasn’t hired until July 29, 2025. Eight months and three amendments (Sixth, Seventh and Eighth) just to move that date. I’ll wait for the filings. They’ll tell us what really happened.
0 · Reply
PolyesterJacket
PolyesterJacket Jul. 31 at 8:14 PM
$BTAI I know it's hard to believe, but management was silent today. This is very uncharacteristic for them.
2 · Reply
JOEYD05
JOEYD05 Jul. 31 at 8:13 PM
$BTAI 👇🤡🤡🤡 👇
0 · Reply
Paxhawig
Paxhawig Jul. 31 at 2:33 PM
0 · Reply
Tonyboner
Tonyboner Jul. 31 at 2:02 PM
$BTAI They better raise soon or the raise price will be below 50c
0 · Reply
WenABVEAudit
WenABVEAudit Jul. 31 at 1:46 PM
$BTAI wtf??
0 · Reply
Paxhawig
Paxhawig Jul. 31 at 1:19 PM
$BTAI soon non compliant with bid price and marketcap
1 · Reply
Paxhawig
Paxhawig Jul. 31 at 1:02 PM
$BTAI offerings soon
0 · Reply
Paxhawig
Paxhawig Jul. 31 at 12:56 PM
$BTAI infortunately
0 · Reply
modernaproblema
modernaproblema Jul. 31 at 12:52 PM
$BTAI 🤞
0 · Reply
SrTxan
SrTxan Jul. 31 at 12:19 PM
$BTAI Today the shorts will likely try to take advantage of the uncertainty. I’ll wait for the filings. Facts over fear.
0 · Reply
Paxhawig
Paxhawig Jul. 31 at 7:55 AM
$BTAI Chapter 11
0 · Reply
Dyliegoat
Dyliegoat Jul. 31 at 2:19 AM
$BTAI ive been averaging down so long idc care anymore. We are goin down like the toys in toy story 3. Holding hands in the incinerator hopefully the little aliens show up with the CLAAAAWWWW.
1 · Reply
ZXSpectrumNext
ZXSpectrumNext Jul. 30 at 7:49 PM
$BTAI 💸added
1 · Reply